Literature DB >> 15953369

ALS-IgG-induced selective motor neurone apoptosis in rat mixed primary spinal cord cultures.

M Demestre1, A Pullen, R W Orrell, M Orth.   

Abstract

There is evidence that in sporadic amyotrophic lateral sclerosis (ALS) immunological mechanisms may be involved in the pathophysiology of the disease. We tested whether purified IgG from ALS patients induce cell death in rat mixed primary spinal cord cultures and compared this with the effect of IgG purified from patients with Guillain-Barré syndrome (GBS) or from healthy donors. Treatment with ALS-IgG increases caspase-3 apoptosis when compared with control IgG or with GBS-IgG, but does not induce death by necrosis. Because ALS is characterized by the selective loss of motor neurones, we next assessed the differential effect of ALS-IgG on motor neurones or astrocytes. We showed, semiquantitatively, that motor neurones are more susceptible to apoptosis when cultures were treated with ALS-IgG compared with control-IgG. In conclusion, we have demonstrated in primary spinal cord cultures that IgG from patients with ALS induces apoptosis selectively in motor neurones, and that the caspase-3 pathway is involved. This suggests that immunological mechanisms may contribute to the selective loss of motor neurones in ALS.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15953369     DOI: 10.1111/j.1471-4159.2005.03184.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  18 in total

1.  The C9orf72-interacting protein Smcr8 is a negative regulator of autoimmunity and lysosomal exocytosis.

Authors:  Yingying Zhang; Aaron Burberry; Jin-Yuan Wang; Jackson Sandoe; Sulagna Ghosh; Namrata D Udeshi; Tanya Svinkina; Daniel A Mordes; Joanie Mok; Maura Charlton; Quan-Zhen Li; Steven A Carr; Kevin Eggan
Journal:  Genes Dev       Date:  2018-06-27       Impact factor: 11.361

2.  Anti-superoxide dismutase antibodies are associated with survival in patients with sporadic amyotrophic lateral sclerosis.

Authors:  Marka van Blitterswijk; Sunita Gulati; Elizabeth Smoot; Matthew Jaffa; Nancy Maher; Bradley T Hyman; Adrian J Ivinson; Clemens R Scherzer; David A Schoenfeld; Merit E Cudkowicz; Robert H Brown; Daryl A Bosco
Journal:  Amyotroph Lateral Scler       Date:  2011-11

3.  Cerebrospinal Fluid from Sporadic Amyotrophic Lateral Sclerosis Patients Induces Mitochondrial and Lysosomal Dysfunction.

Authors:  Aparna Sharma; Anu Mary Varghese; Kalyan Vijaylakshmi; Rajendrarao Sumitha; V K Prasanna; S Shruthi; B K Chandrasekhar Sagar; Keshava K Datta; Harsha Gowda; Atchayaram Nalini; Phalguni Anand Alladi; Rita Christopher; Talakad N Sathyaprabha; Trichur R Raju; M M Srinivas Bharath
Journal:  Neurochem Res       Date:  2015-12-08       Impact factor: 3.996

4.  Calcium signaling pathways mediating synaptic potentiation triggered by amyotrophic lateral sclerosis IgG in motor nerve terminals.

Authors:  Mario R Pagani; Ricardo C Reisin; Osvaldo D Uchitel
Journal:  J Neurosci       Date:  2006-03-08       Impact factor: 6.167

5.  Autoimmunity in amyotrophic lateral sclerosis: past and present.

Authors:  Mario Rafael Pagani; Laura Elisabeth Gonzalez; Osvaldo Daniel Uchitel
Journal:  Neurol Res Int       Date:  2011-08-01

Review 6.  The Role of immune and inflammatory mechanisms in ALS.

Authors:  P A McCombe; R D Henderson
Journal:  Curr Mol Med       Date:  2011-04       Impact factor: 2.222

7.  Glycans in sera of amyotrophic lateral sclerosis patients and their role in killing neuronal cells.

Authors:  Meital Edri-Brami; Benyamin Rosental; Dana Hayoun; Michael Welt; Hila Rosen; Itzhak Wirguin; Beatrice Nefussy; Vivian E Drory; Angel Porgador; Rachel G Lichtenstein
Journal:  PLoS One       Date:  2012-05-30       Impact factor: 3.240

Review 8.  Neuroimmunity dynamics and the development of therapeutic strategies for amyotrophic lateral sclerosis.

Authors:  Melissa Bowerman; Thierry Vincent; Frédérique Scamps; Florence E Perrin; William Camu; Cédric Raoul
Journal:  Front Cell Neurosci       Date:  2013-11-19       Impact factor: 5.505

9.  Recent advances in amyotrophic lateral sclerosis research: perspectives for personalized clinical application.

Authors:  Chen Benkler; Daniel Offen; Eldad Melamed; Lana Kupershmidt; Tamar Amit; Silvia Mandel; Moussa B H Youdim; Orly Weinreb
Journal:  EPMA J       Date:  2010-06-29       Impact factor: 6.543

Review 10.  Novel molecular biomarkers at the blood-brain barrier in ALS.

Authors:  Danijela Bataveljic; Milena Milosevic; Lidija Radenovic; Pavle Andjus
Journal:  Biomed Res Int       Date:  2014-05-11       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.